1.Make the overall business plan of online and offline pharmacy integration in anti-tumor field of Jingdong Health, ensure the correct implementation of the business plan, and be responsible for the gross profit margin and GMV of anti-tumor drugs of Jingdong Health; 2.Responsible for the expansion and maintenance of customers of key pharmaceutical enterprises, and jointly build a good cooperation ecosystem; 3.Insight into pharmaceutical market and policy trends, note the competitive environment.According to the introduction of national policies such as VBP and NRDL, the opportunity points of Jingdong Big Pharmacy will be explored and the way of product innovation and growth will be explored;

Job Contents1) Marketing experience of new products: as the brand leader of Imatinib, I worked closely with the medical Department, sales Department, market access department and drug Research Institute.2) Prepare for the market through close cooperation, including product packaging, resume of expert system and preparation of the first marketing materials.As a supporter of bortezomib and Lenalidomide listing, I was responsible for in-depth understanding of competitive product information, setting up media publicity, expert interviews, listing meeting, national meeting and clinical research projects;3) Mature brand management experience: set up the management system of Sidaxin, responsible for formulating annual market strategy, formulating corresponding promotion plan, formulating corresponding promotion activities according to the market strategy, and organizing, implementing, evaluating and improving the activities;Compared with 2019, the market share of Sidaxin will increase from 16.11% to 19.75% in 2020.Comparing with 16 competitive products, the company was promoted from the fourth to the third in the industry to realize the transformation from a market follower to a market leader.4) Core strategic project management experience: according to the company's development strategy, I independently took charge of the core strategic project cooperation between the company and the International Myeloma Working Group, The Chinese Immunology Society and the Bethune Foundation. MRD project fills the blank of MRD technology detection in China.To create a cooperative brand of "Only Aikeda * Bethune Foundation".In the form of case collection, clinical research and academic research, the company has set up special cooperation platforms with The Chinese Society of Immunization, s.To provide strategic support for the increase of lenalidomide and bortezomib market share;